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ABSTRACT 
Epilepsy has become second most common neurological disorder affecting 70 million people worldwide. Several shortcomings appeared with the 
use of conventional antiepileptic drugs (AEDs) like, inadequate seizure control, side effects, cost, potentiation of epilepsy-induced co-morbidities, 
etc., which limit their use as comprehensive therapy. Phytoflavonoids in this regard have been observed to be promising AEDs which can interact 
with most of the possible targets involved in the pathogenesis of epilepsy. They show  modulatory effect on voltage gated sodium channels, calcium 
channels, potassium channels, GABAergic system, opioid receptors, NMDA receptors and posses a strong antioxidant effects through modulation of 
nitric oxide pathway, xanthine oxidase system and through leukocytic immobilization. Along with antiepileptic effect, flavanoids have also been 
observed to ameliorate memory deficit and mood disorders commonly associated with AEDs treatment. Based on the vast literature reports, an 
attempt has been made to collate the fragmented information available on flavonoids, to access there potential as antiepileptics for future. From this 
review it is cleared that, flavonoids open new encouraging perspectives for the antiepileptic treatment. A prospective randomized trial of flavonoids 
may be justified in humans. 
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INTRODUCTION 
The name epilepsy is derived from a Greek word "epilambanein", 
which means "to seize upon", "to attack". Epilepsy is characterized 
as a chronic brain disorder in which there is tendency of the patient 
to experience periodic, unpredictable recurring seizures with or 
without characteristic body movements, called convulsions [1]. 
Epilepsy is the second most common neurological disorder affecting 
around 70 million people worldwide, out of which approximately 80 
% are in developing countries [2].  
Around 60-70% of the total patients with epilepsy depend on the 
medical treatment with antiepileptic drugs (AEDs) to achieve con-
trol of their epileptic seizures. These AEDs are targeted on supress-
ing an abnormal epileptic discharge, acting generally via one or 
more mechanism(s) through inactivation of Na+(hydantoins, etc) 
and Ca2+ channels (ethosuximide, etc), increasing GABA-mediated 
inhibitory functions (barbiturates, benzodiazepines, etc), inhibition 
of glutamate-mediated excitation (felbamate, etc), activation of K+ 
channels (retigabine) [3-5].  
Despite, decades of advancements in AEDs, there are a lot of short-
comings associated with their use. One-third of the epileptic patients 
treated with the available AEDs do not obtain satisfactory seizure 
control. Moreover, chronic use of these AEDs is associated with 
several systemic and central nervous system adverse effects like, 
fatigue, agressivity, anxiety, headache, hair loss, skin reactions, dip-
lopia or blurred vision, dyspepsia, gingival hypertrophy or bleeding, 
tremors, weight gain, dizziness, somnolence, memory impairment, 
sleep disturbance, lack of concentration, lack of libido, difficulty of 
erection in men [6, 7].  
A majority of epileptic patients suffer from one or more psychiatric 
or somatic comorbid conditions, whose nature and prevalence vary 
with age and sociodemographic factors, these comorbid conditions 
include cognitive deficit, mood disorders, anxiety, etc [8]. In the 
developed countries where drugs are easily available only 70 % 
patients with epilepsy responds to antiepileptic drug therapy. How-
ever, in developing countries 75% of people with epilepsy do not 
receive the treatment they need and their epilepsy remains uncon-
trolled, rendering the patient unproductive in all spheres of life. All 
these issues direct a large proportion of the patients to move on to 
traditional healers and medicinal plants [9]. 
Traditional herbs due to presence of large amount of bioactive active 
ingredients have a great potential to treat epilepsy. Among all, phy-
toflavonoids are the most important bioactive product isolated from 
traditional herbs used in the treatment of epilepsy. "Phyto" is a 
Greek word that means plant, so phtoflavonoids means the flavono-
ids obtained from natural plant resources. Many of the traditional 
plants containing flavonoids have been experimentally explored for 
their anticonvulsant effect. Studies have shown that flavonoids pos-
sess remarkable anticonvulsant activity which can be exploited for 
the development of comprehensive AEDs of future [10-12]. Isolated 
phytoflavonoids like, hispidulin, rutin, hesperetin, naringenin, eri-
odictyol, chrysin, gossypin, apigenin, kaempferol, myricetin, 
quercetin, hyperoside etc. posses GABAergic agonism, sodiumchan-
nels blockade, calciumchannels blockade, glutamate receptors anta-
gonism and antioxidant etc., thereby act as anticonvulsants [13]. 
 Flavonoids also had been found to ameliorate cognition deficit and 
depression, both of which occur in epileptic patient as co-
morbidities. It has also been found that herbal antioxidant like, cur-
cumin have synergistic antiepileptic effect with standard AEDS like 
phenytoin [14]. Curcumin when co-administered with the sub-
effective doses of phenytoin, increased the latency to myoclonic 
jerks and protected against seizures, which was absent in animals 
treated per se with the same dose of phenytoin. Thus, flavonoids are 
turning out to be very useful and indispensable in the struggle for 
seizure management and future AEDs development. The present 
review focuses on antiepileptic flavonoids, their mechanisms, toxi-
cology and their possible efficacy in epilepsy-induced comorbidities.  
FLAVONOIDS 
Flavonoids, also known as Vitamin P, are a class of secondary meta-
bolites that provide UV protection and color to the plant. Nijveldt et 
al. [15] revealed their protective effect on brain stroke and cardi-
ovascular system diseases.  
Chemically, flavonoids are polyphenolic components containing a 
core of 15 carbon atoms; two benzene rings joined by a linear three 
carbon chain. Based upon the position present on basic parent moi-
ety flavonoids are generally classified into 6 subclasses flavones, 
flavonols, isoflavones, flavonones, flavon-3-ols and anthocyanidin 
(Fig. 1). Biologically they are synthesised via acetate and shikimic 
acid pathway into a C6 - C3 - C6 system [17, 18]. 
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Fig. 1: It shows the comprehensive list of all the chemical struc-
tures for the main classes of flavonoids. 
 
Antiepileptic mechanisms of flavonoids  
Flavonoids have been found to inhibit almost all the mechanisms 
involved in seizures generation in epilepsy. They have been found to 
modulate neuronal Na+ channels, Ca2+ channels, GABA ergic path-
way, glutamatergic pathway and opioid pathway (Fig. 2).  
1. Inhibition of voltage gated Na+channels resulting in decrease 
sodium ion influx into the neuronal cell 
2. Activation of Ca+activated K+channels resulting in increased 
potassium ion outflow from thr neuronal cell 
3. Activation of inhibitory GABAergic receptors through direct ac-
tion on GABA or through benzodiazepine receptor resulting in in-
creased chloride ion influx causing neuronal hyperpolarisation 
4. Inhibition of opioid receptors leading to proconvulsant or 
anticonvulsant effects 
5. Antioxidant effects of flavonoids leading to increased seizure 
threshold. 
6. Inhibition of NMDA receptor, resulting in decrease entry of 
calcium into the neuronal cell 
 
 
Fig. 2: Schematic antiepileptic mechanism of flavonoids. 
 
Inhibition of voltage gated sodium channels  
Abnormal increase in intracellular Na+ causes high neuronal excita-
bility leading to excessive depolarization leading to seizures. Several 
clinically used drugs like, Phenytoin, Carbamazepine, Valproic acid, 
etc. act via blockade of sodium channels, inhibiting abnormal depo-
larization. Flavonoids such as quercetin and pinostrobin have been 
found to act through similar mechanism [19]. Quercetin also de-
creases the amplitudes of sodium currents at different membrane 
potentials in rat hippocampal CA1 pyramidal neurons [20]. 
Activation of Ca+activated K+ channels  
Repetitive ictal and interictal activity causes increase in extracellular 
K+, leading to increased neuronal excitability. Neurons are very sen-
sitive to changes in membrane K+ currents, e.g. pyramidal cells in 
CA1 region of the hippocampus. Mutation in these voltage-gated K+ 
channel causes benign familial neonatal convulsions [21]. Retigabin 
is a clinically used antiepileptic drug and act by opening K+ channels. 
Flavonoids like quercetin have been reported to activate Ca2+-
activated K+ channels and decreases extracellular K+ leading to hy-
perpolarization amelioration of seizures [22]. 
GABAergic inhibition  
GABA (γ-aminobutyric acid) is the principal inhibitory neurotrans-
mitter in the mammalian CNS. GABA elicits inhibitory response in 
the brain via three classes of receptors, GABAA, GABAB and GABAC. 
GABAA is a GABA gated chloride channel which allows influx of chlo-
ride ions resulting in decrease excitatory stimulus [23].  
The GABAB receptor is a G-protein coupled metabotropic receptor 
which interacts with Gi to inhibit adenylyl cyclase, activate K+ chan-
nels and reduce Ca2+ conductance. The GABAC receptor is a transmit-
ter-gated Cl- channel and is less widely distributed than the A and B 
subtypes [24].  
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The GABA hypothesis of epilepsy implies that a reduction of GABA-
ergic inhibition results in epilepsy, whereas an enhancement of 
GABA-ergic functions results in an antiepileptic effect. Modulation of 
ionotropic GABA receptors by a group of natural and synthetic fla-
vonoids has been extensively studied in several experimental stu-
dies. Literature survey showed that, quercetin, apigenin, morine, 
chrysin and flavone inhibit ionic currents mediated by GABAA and 
GABAC receptors expressed in Xenopus laevis oocytes leading to 
suppression of abnormal depolarization [21, 25]. Flavonoids like 
apigenin and (-) epigallocatechin gallate potentiates the therapeutic 
effect of diazepam [26], indicating their efficacious role in combined 
therapy. This synergistic effect of flavonoids is due to their binding 
affinity with GABAA receptor through high-affinity flumazenil-
sensitive site or low-affinity, flumazenil-insensitive site [25]. 
Benzodiazepines (BDZ) also play a vital role in ameliorating epilepsy 
and act by enhancing GABAergic functions leading to reduction in 
sustained repetitive firing. But because of their depressant nature 
they show several side effects. Whereas, flavones like, 6,3-
dinitroflavone act by similar GABAergic action as that of BDZ sites 
but devoid of side effects like, ataxia, amnesia, etc [21, 27].  
Opioid receptor interactions 
Opioid receptors are found in various brain regions and spinal me-
dulla, as well as in intramural nerve plexuses. These receptors are 
classified as μ, δ and κ, they mediate their physiological functions 
through G-protein coupled mechanism. Activation of these receptors 
causes increase in K+ conductance, decrease in Ca2+influx into nerve 
terminal leading hyperpolarization, decreased release of excitatory 
neurotransmitters and decreased synaptic activity. Depending on 
the cell population affected, the synaptic inhibition translates into 
depressant or excitatory effects. Studies have shown that opioids 
and opioid peptides had both convulsant and anticonvulsant proper-
ties. Several flavonoids have been evaluated for their opioid receptor 
modulatory effects. Amentoflavone and hyperoside present in H. 
perforatum have κ antagonist activity in vitro [21]. Katavic [28] also 
suggested flavonoid core as a future new scaffold for the develop-
ment of opioid receptor ligands. 
Inhibition of NMDA receptors 
Excessive activation of glutamatergic N-Methyl-D-aspartate (NMDA) 
receptor leads to neuronal degeneration and death, due to increased 
Ca2+ concentration in the postsynaptic neurons leading to abnormal 
neuronal depolarisation. Binding of Ca2+to calmodulin also activates 
nitric oxide synthase, thereby increasing the formation of nitric 
oxide (NO) that contributes to the neurotoxic effects. Moreover, 
activation of NMDA receptors also leads to increased production of 
superoxide radicals, leading to the generation of hydroxyl radicals 
causing oxidative damage which is responsible for worsening of 
epileptic condition and initiates its associated comorbidites. NMDA 
receptor antagonists are powerful anticonvulsant and are clinically 
used. They are responsible for the inhibition of calcium influx into 
the neurons thereby preventing abnormal excitation. Several flavo-
noids like, morin, kaemferol, myricetin, quercetin, anghyperoside 
have been reported to block glutamatergic excitation mediated 
through NMDA receptors. Morin provides neuroprotection by inhib-
iting excessive activation of NMDA receptors, NMDA receptor medi-
ated neurotoxicity [29]. Thus, flavonoids like morin can be helpful in 
developing NMDA antagonists which can be effectively used for the 
treatment of epilepsy and its associated comorbidities in future. 
Antioxidant potential  
Free radicals play a crucial role in the pathogenesis of epilepsy. In-
crease in number of free radicals is coupled with low level of anti-
oxidants, which results in the neuronal damage. It has been reported 
that free radical generation induces seizure activity by inactivation 
of glutamine synthase, leading to an abnormal build-up of excitatory 
neurotransmitter, glutamate or by decreasing glutamate decarbox-
ylase, thus causing decrease in GABA turnover [13]. Flavonoids in 
this regard prove out to be a bioactive metabolite of choice for the 
treatment of oxidative stress induced diseases like, epilepsy. Tradi-
tionally also plants containing flavonoids have been experimentally 
explored for their anticonvulsant effect [10-12]. Flavonoids possess 
high antioxidant activity and low IC50 in in vitro antioxidant tests like 
2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay [30]. 
IC50 is the concentration at which the substance shows 50% inhibito-
ry activity. Ishige et al. [31] found three distinct mechanisms of anti-
oxidant protection like, increasing intracellular GSH, directly lower-
ing levels of ROS, and preventing the influx of Ca2+ despite high le-
vels of ROS.  
Not all flavonoids have equal antioxidant potential. Flavonols were 
found to be best antioxidants when compared with anthocyanidins, 
flavone and flavanone and other type of flavonoids [32, 33]. Flavo-
nols like goodyerin, quercetin, rutin can be used to effectively con-
trol epilepsy [11, 34-36]. Flavonols like quercetin and kaempferol 
are also reported for reversing oxidative stress induced-decrease of 
hippocampal BDNF and pCREB expression and leading to hippo-
campal neurogenesis and thus, ameliorating depression and cogni-
tive deficit [37, 38].  
Direct radical scavenging 
Flavonoids have a highly reactive hydroxyl group in their structure. 
It reacts with free radical resulting into more stable less-reactive 
radical, thus providing direct radical scavenging activity [30]. Hana-
saki et al. [40] studied the abilities of 15 flavonoids as a scavenger of 
active oxygens (hydroxyl radical and superoxide anion). Hydroxyl 
radical (.OH) which was generated by the Fenton system, and as-
sayed by the amount of methanesulfinic acid (MSA) formed from the 
reaction of dimethyl sulfoxide (DMSO) with. OH (+)-Catechin, epica-
techin, 7,8-dihydroxy flavone, and rutin showed the. OH scavenging 
effect almost 100-300 times superior to that of mannitol, a typical. 
OH scavenger.  
Modulation of nitric oxide pathway 
Increased levels of nitric-oxide synthase in macrophages enhance 
the production of both nitric oxide and superoxide anions. Nitric 
oxide when reacts with free radicals causes production of peroxini-
trite, which are highly damaging to the cell. Flavonoids like silibin 
have been found to scavenge nitric oxide and free radicals directly 
(Fig. 3) [41, 42]. 
 
 
Fig. 3: It shows the pathway exhibited by flavonoids in scaveng-
ing action on nitric oxide radical; NO means nitric oxide, SOX 
means superoxide and R.means free radical. 
 
Xanthine oxidase 
During oxidative injury to tissues xanthine dehydrogenase gets con-
figurationally changed to xanthine oxidase which is an important 
source of oxygen free radicals. Flavonoids such as quercetin, silibin, 
luteolin etc. inhibit xanthine oxidase activity, thereby resulting in 
decreased oxidative damage [44, 44]. Luteolin (3,4_5,7- tetrahy-
droxyflavone) have been found to be the most potent inhibitor of 
xanthine oxidase [45]. 
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Leukocyte immobilization 
Oxidative endothelium damage, as a consequence of ischaemia re-
sults in generate of endothelium derived mediators and complement 
factors, which cause adhesion of leukocytes to the endothelial wall 
and stimulating degranulation of neutrophils. As a result, oxidants 
and inflammatory mediators are released, resulting in tissue injury. 
Flavonoids due to modulation of receptor-directed Ca2+ channels in 
the plasma membrane [46] have been found to decrease the genera-
tion of various mediators and ameliorate oxidative stress [47, 48].  
A majority of the above mentioned studies have been carried out in 
in vitro assay. In future the antioxidant effect of flavonoids can be 
further studied in the in vivo models of epilepsy to further under-
stand and explore the mechanism involved in their anticonvulsant 
action.  
Effect of flavonoids on epilepsy-induced comorbidities  
Majority of epileptic patients suffer from one or more psychiatric or 
somatic comorbid conditions, whose nature and prevalence vary 
with age and sociodemographic factors, the most common comorbid 
conditions include, cognitive deficit and mood disorder. In these 
patients, comorbid conditions have a major adverse effect on overall 
health and quality of life and substantially increase health care costs 
[8]. Moreover, majority of antiepileptic drugs are consumed life long, 
concomitant administration predisposes to high risk of adverse-
effects and drug interaction. Treatment with these conventional 
AEDs is associated with the brain dysfunction such as hippocampal 
atrophy causing memory disorders and mood disorders with a cas-
cade of pervasive psychosocial problems. Phenobarbital and topi-
ramate has the greatest potential to affect cognitive defect while 
levetiracetam, topiramate, zonisamide and phenobarbital has poten-
tial to cause behavioral adverse-effects [7]. Therefore, satisfactory 
treatment of epilepsy not only demands the suppression of abnor-
mal neuronal discharge but also control of epileptic comorbidities 
associated with it. 
During seizures the blood flow to the brain increases due to imme-
diate increase in the diameter of pial arterioles and major resistance 
vessels of the brain that determine the cerebral blood flow. This 
increased cerebral blood flow is required to match increased oxygen 
and other metabolic demands of the activated neurons during the 
epileptic seizures [49]. This increased blood flow increases the me-
tabolic load on the brain causing abnormal generation of free radi-
cals. Excessive generation of free radicals like reactive oxygen spe-
cies (ROS) and reactive nitrogen species (RNS) are the key factors 
that react with endogenous substrates like, fatty acids, proteins and 
DNA, causing oxidative damage [50-52]. Oxidative and nitrosative 
stress also activates neutrophils and monocytes that cause nitration 
and nitrosylation of proteins to generate inactive autoepitopes to 
neoantigens which acquire immunogenicity and causes autoimmune 
responses [53]. It also induces decrease in hippocampal BDNF and 
pCREB expression leading to hippocampal cells degeneration. These 
pathways in turn generate neurodegenerative process mainly re-
sponsible for the induction of comorbid conditions. Oxidative stress 
is also established in the genesis of cognitive deficit associated with 
epilepsy via interaction with several pathways like, CREB, PI3K, PKG, 
ERK1/2 etc [54-58]. Flavonoids, due to their antiepileptic and neu-
roprotective effects have been found to ameliorate the comorbities. 
They interact with critical protein and lipid kinase signaling cas-
cades, such as phosphatidylinositol-3 kinase (PI3K)/Akt, protein 
kinase C and mitogen-activated protein kinase in the brain, leading 
to inhibition of apoptosis triggered by neurotoxic species and pro-
mote neuronal survival and synaptic plasticity. Secondly, flavonoids 
induce beneficial effects on the vascular system leading to changes 
in cerebrovascular blood flow capable of causing angiogenesis, neu-
rogenesis and changes in neuronal morphology [59]. 
Flavonoids and memory deficit 
Flavonoids due to their remarkable antioxidant activity act to ameli-
orate cognitive deficit mainly by three common processes. Firstly, 
they interact with critical protein and lipid kinase signaling cascades 
such as phosphatidylinositol-3 kinase (PI3K)/Akt, protein kinase C 
and mitogen-activated protein kinase in the brain, leading to an 
inhibition of apoptosis triggered by neurotoxic species and to pro-
mote neuronal survival and synaptic plasticity. Secondly, flavonoids 
induce beneficial effects on the vascular system by decreasing reac-
tive oxygen species and increasing nitric oxide bioavailability. It 
leads to changes in cerebrovascular blood flow capable of causing 
angiogenesis, neurogenesis and changes in neuronal morphology by 
activating PI3 kinase-Akt-eNOS system. Angiogenesis is followed by 
neurogenesis. Thirdly, flavonoid activate ERK and Akt pathway lead-
ing to activation of CREB pathway causing the release of neurotro-
phins such as BDNF and activate PI3 kinase-mTOR cascade and Arc/ 
Arg3.1 which results in changes in synaptic plasticity and Long Term 
Potentiation(LTP) [59, 60]. Flavonoids such as flavonols, anthocya-
nins and flavonones have much better potential to ameliorate cogni-
tive process. Isoflavone supplementation has been observed to have 
a favorable effect on verbal memory and on postmenopausal wom-
en. Isoflavones have been to mimic the actions and functions of oes-
trogens in the brain. Pure flavonols such as quercetin, rutin or fisetin 
have provided further evidence that dietary flavonoids are beneficial 
in reversing the course of neuronal and behavioural aging. The fla-
vonoid-rich plant extract, Ginkgo Biloba has also been shown to 
induce positive effects on memory, learning and concentration. Fise-
tin, a flavonoid isolated from strawberries, has been shown to im-
prove long-term potentiation and to enhance object recognition in 
mice.  
The central cholinergic system plays an important role in learning 
and memory [61-62]. AChE (acetylcholinesterase), the main enzyme 
that hydrolyses acetylcholine, increases in the experimental and 
clinical epilepsy [63-65] and elevated AChE level has been suggested 
as pathogenic factor for memory deficit [66]. Acetylcholinesterase 
inhibitors have been shown to function by increasing the level of 
acetylcholine within the synaptic region, thereby restoring deficient 
cholinergic neurotransmission [69]. It has been reported that flavo-
noids like flavonols galangin, kaempferol, quercetin, myricetin, fise-
tin; flavons – apigenin, luteolin, and flavonol-glycoside quercetin-3-
rutinoside (rutin) inhibits human AChE thereby effects memory 
functions. It has been found that AChE inhibition potency increase 
from rutin < apigenin < fisetin < kaempferol < galangin < luteolin < 
quercetin ≤ myricetin. It seems that larger number of OH groups on 
the side phenyl ring would result in the more pronounced AChE 
inhibition like in case of flavonols; quercetin and myricetin [67].  
Since majority of aforesaid flavonoids have shown antiepileptic 
effects, their memory enhancing effect indicate that these flavonoids 
can be used for the treatment of epilepsy without the risk of memory 
impairment, provided their memory enhancing effect during epilep-
tic condition is studied in future.  
Flavonoids and mood disorders 
Flavonoids extracted from plants are known to exert antidepressant 
like effects in animal models of depression [68, 69]. Naringenin a 
dietary flavonoid possessing neuroprotective actions in various 
central pathophysiological conditions including depression [70]. 
Xiaobuxin-Tang (XBXT), a traditional Chinese herbal decoction, has 
been used for the treatment of depressive disorder for centuries in 
China. It is reported to contain a large amount of flavonoids which 
on treatment reversed behavioral alterations including depression 
[37]. Similarly flavonoid-rich extract of Hypericum perforatum main-
ly containing quercetin and hyperoside flavonols [71] and flavonoids 
of Scutellariae radix were found to be responsible for antidepressant 
action [72]. Flavonoids, mainly flavonols like, quercetin and kaemp-
ferol are responsible to revert the oxidative stress induced-decrease 
of hippocampal BDNF and pCREB expression, leading to hippocam-
pal neurogenesis and thus, ameliorating depression [37, 38]. These 
antidepressant effects of flavonoids can be further studied in epilep-
sy-induced depression to further expand their therapeutic potential 
in epilepsy. 
Flavonoidal plants as antiepileptic 
In several previous studies flavonoidal plants have been studied for 
their anticonvulsant activity in different animal models of convul-
sions. In this section, we have tried to summarize and discussed 
about the plants containing flavonoids that have been screened for 
their anticonvulsant activity (also summarized in Table 1). These 
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plants can be further explored in future as in majority of cases the 
information regarding the particular type of flavonoid involved for 
the anticonvulsant activity, exact mechanism of action, safety, etc. is 
lacking.  
Anisomeles malabarica (L) R. Br 
Anisomeles malabarica is an herbaceous Australian plant belonging 
to family Lamiaceae, it is a plant of immense use and utility in folk 
medicine. It has been used for the treatment of epilepsy. Choudhary 
et al. [73] studied the anticonvulsant effect of flavonoidal-rich frac-
tion from the leaves of A. malabarica. In the study the ethyl acetate 
fraction containing flavonoid showed antiepileptic activity against 
pentylenetetrazole (PTZ) and maximal electroshock (MES)-induced 
convulsions in wistar rats. Chronic treatment with the fraction at 
doses of 6.25 and 12.5 mg/kg i.p. for 1 week has showed significant 
anticonvulsant effect without any signs of neurotoxicity. Further 
research is required to determine the active responsible flavon-
oid(s) and their exact mechanism of action. 
Glychrrhiza glabra L. 
G. glabra (Febaceae) also known as liquorice is native to southern 
Europe and parts of Asia. It is commonly known as "Mulaithi" in 
Northen India. It has been found to contain antioxidant substances 
like, ascorbic acid (0.58 g %) and flavonoids (0.926 g %) such as 
glabridin (an isoflavan) and isoliquiritigenin (a flavonoid) [74]. Am-
bawade et al. [75] studied its anticonvulsant activity using MES, PTZ 
and lithium-pilocarpine-induced convulsion mice models. Its etha-
nolic extract of roots and rhizomes containing flavonoids at 10, 30, 
100 and 500 mg/kg i.p. doses inhibited PTZ and lithium-pilocarpine-
induced convulsions, but was found to be ineffective against MES-
induced convulsions. The extract was found to be safe up to 1g/kg 
i.p. dose in mice. Since it is rich in flavonoids, hence it is expected 
that the observed anticonvulsant effect can be due to their presence, 
however more studies are required to fulfill these expectations.  
Passiflora incarnate L. 
P. incarnate commonly known as passion flower/maypop/apricot 
vine belongs to family Passifloraceae. It was discovered in 1569 by 
Spanish explorers in Peru. The local Indians used it to soothe their 
nerves and topically as a poultice, the crushed leaves being used on 
cuts and bruises [76]. Phytochemical research carried out on Passif-
lora incarnata had lead to the isolation of several flavonoids like, 
chrysin, apigenin, homoorientin, vitexin, luteolin, quercetin, kaemp-
ferol, isovitexin, orientin, isoorientin, etc. The anticonvulsant effect 
of the hydroethanolic extract of its aerial parts has been extensively 
explored and has been suggested to be due to presence of flavonoids like 
chrysin that act by agonizing benzodiazepine receptor [27, 77, 78].  
Scutellaria lateriflora L. 
It belongs to family Lamiaceae and is commonly known as American 
Skullcap. S. lateriflora has been used for the treatment of epilepsy 
and several other neurological disorders in traditional medicine. 
Zhang et al. [79] isolated and identified 10 flavonoids, viscidulin III-
2-O-β-D-glucopyranoside, chryin-6-C-α-L-arabionopyranosyl-8-C-β-
D-glucopyranoside, trans-verbascoside, viscidulin III, baicalin, trans-
martynoside, oroxylin A-7-O-β-D-glucopyranoside, wogonoside, 
baicalein, wogonin from whole extract of skull cap. In the same 
study, the anticonvulsant effect of the hydroalcoholic extract of 
whole skullcap at 90 mg/kg i.p. showed significant protection 
against PTZ-induced convulsions. The flavonoids present in the 
extract like wogonin which is known to have anticonvulsant activity 
[80] may be the active ingredients responsible for the anticonvul-
sant activity of American skullcap as they show high affinity for the 
benzodiazepine binding site at GABAA receptor [81] and have anti-
oxidant effects [82, 83]. 
Drosera burmanni Vahl 
The genus Drosera is popularly known as Sundew and is the largest 
genus of carnivorous plants with over 105 species belonging to the 
family Droseraceae. Flavonoids like kaempferol, myricetin, quercetin 
and hyperoside have been isolated from D. burmanni [84]. Hema et 
al. [85] studied the anticonvulsant activity of the alcoholic extract of 
whole plant at a dose of 500 mg/kg p.o. The extract significantly 
delayed the onset of PTZ-induced convulsions in swiss albino mice. 
This anticonvulsant activity may be attributed because of flavonoids 
as the flavonoids like quercetin and kaempferol are known to be 
responsible for anticonvulsant activity [86] and kaempferol, myrice-
tin, quercetin are also reported to have neuroprotective effects [87]. 
Flavonoids due to reduction of T-type calcium currents, enhance-
ment of GABAA-BZD receptor activity and blocking of glutametargic 
excitation mediated by NMDA receptors can effectively inhibit PTZ-
induced convulsions.  
Cleome viscose L. 
C. viscose also known as Dog mustard belongs to family Capparida-
ceae. Its fresh juice of crushed seeds has been used for treatment of 
infantile convulsions and other mental disorders. In a recent study, 
the anticonvulsant activity of its ethanol and aqueous seed extract 
containing flavonoids has been studied [88]. The extracts at 200, 
400 and 600 mg/kg p.o. doses prevented MES and PTZ-induced 
convulsions in mice. The anticonvulsive effect might be because of 
flavonoids attributed due to inhibitory effect on voltage dependent 
sodium channels or due to blockage of glutaminergic excitation. 
However further studies are required to find out the exact role and 
types of flavonoids responsible for the activity. 
Caesalpinia bonducella (L.) Roxb.  
It is a prickly shrub belonging to family Caesalpiniaceae and is com-
monly known as Nata Karanja. It is found throughout the hot regions 
of India, Myanmar and Sri Lanka. Ali et al. [89] investigated the anti-
convulsant activity of the petroleum ether extract of its seed kernel. 
Phytochemical screening showed the presence of flavonoids like 
homoisoflavone (bonducillin) in the petroleum ether extract. The 
petroleum ether extract at chronic doses of 600 and 800 mg/kg p.o. 
for 8 days prevented PTZ, MES, strychnine and picrotoxin-induced 
convulsions in swiss albino mice. Anticonvulsant activity might be 
because of flavonoids, but still it is not clear that the effect of extract 
is due to flavonoids or some other bioactive metabolite, more stu-
dies are required in this area. 
Vitex negundo L. 
V. negundu commonly known as five-leaved chaste tree or Monk’s 
Pepper belongs to family Verbenaceae. It was used in Iranian ancient 
medical schools and Alkandi for the treatment of epilepsy and psy-
chosis, in India it is also used as antiepileptic. Its methanolic leaf 
extract showed protection against strychnine and PTZ induced con-
vulsions [90]. Tandon [91] reported the anticonvulsant activity of its 
petroleum and butanolic leaf extracts against MES-induced convul-
sion model. The extracts showed the presence of flavonoids like, 
flavones. In another study treatment with its ethanolic leaf extract 
not only showed anticonvulsant activity, but also potentiated the 
anticonvulsant effect of standard antiepileptic drugs when used in 
combination [92]. The study suggested that flavanoids can be used 
in combination with standard antiepileptic drugs to increase efficacy 
and mask side effects of latter, provided the safety of combined 
treatment is warrant in future research.  
Ocimum gratissimum L. 
O. gratissimum also known as African Basil belongs to family Lamia-
ceae. Vieira et al. [93] reported the presence of Eugenol, thymol, and 
geraniol as the major volatile oil constituents and Xantomicrol and 
cirsimaritin as the major external flavones. Okoli et al. [94] studied 
the anticonvulsant activity of its leaves containing eugenol (volatile 
oil) and cirsimaritin (flavones) using PTZ model in mice. Methanolic 
and petroleum ether extract of leaves were administered at the 
doses of 200 and 400 mg/kg p.o. and was found to increase the la-
tency of seizures and death and elicited 50% protection against 
mortality. As the studies aimed at isolating the anticonvulsant con-
stituents of this plant are ongoing but still the role of flavonoids as 
anticonvulsant cannot be ruled out. 
Centella asiatica (L.) Urban 
It is commonly known as Gotu Kola and belongs to family Umbellife-
rare. It has been used in Indian traditional medicine as a memory 
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enhancer, treatment of neurological disorders (insomnia, hysteria, 
insanity, epilepsy, etc) and skin diseases. Its leaves contain flavono-
ids like, 3-glucosylquercetin, 3-glucosylkaempferol and 7-
glucosylkaempferol [95]. Visweswari et al. [96] studied the anticon-
vulsive activity of its n-hexane, chloroform, ethyl acetate, n-butanol 
leaf extracts. Treatment with all the extracts except aqueous extract 
at 200 mg/kg b.w. 1 week prior to dose of PTZ showed significant 
protection against PTZ-induced convulsions in male wistar rats. It 
was found that the activities of Na+, K+-ATPase, Mg2+-ATPase, and 
Ca2+-ATPase in brain (cerebral cortex, cerebellum, pons medulla and 
hippocampus) were significantly increased after treatment with 
different C. asiatica extracts which in general is decreased after PTZ 
induced epilepsy in all the above brain regions.  
Cissus sicyoides L. 
C. sicyoides (Vitaceae) has been evaluated for its anticonvulsant 
activity. Phytochemical exploration had led to the isolation of two 
flavonoids, kaempferol 3-rhamnoside and quercetin 3-rhamnoside 
from its aerial parts [97]. De Almeida et al. [98] studied the anticon-
vulsant activity of the hydroalcoholic extract of the aerial parts of C. 
sicyoides. Treatment with the extract at 600 and 1000 mg/kg i.p. 
doses inhibited PTZ-induced convulsions in mice. Since, kaempferol 
and quercetin have been reported to have anticonvulsant activity, 
and kaempferol 3-rhamnoside and quercetin 3-rhamnoside are their 
flavano-glycosidic forms, hence the activity of the extract can be due 
to these metabolites. The glycosidic part conjugated with the flavo-
noid will increase solubility thus showing better pharmacokinetic 
property and increasing the anticonvulsant effects of these flavono-
ids. More studies are required to confirm the exact role of these 
flavano-glycosides for the observed anticonvulsant effect of C. si-
cyoides extract. 
Ficus hispida L. 
F. hispida is a medicinally important member of family Moraceae. 
Dhanasekaran et al. [99] studied the anticonvulsant effect of its 
methanolic leaf extract containing flavonoids, using strychnine, 
picrotoxin, and PTZ mice models of convulsions. Treatment with the 
extract at 400 mg/kg p.o. dose completely abolished the seizures 
induced by picrotoxin and strychnine, but was found to be ineffec-
tive against PTZ-induced convulsions. Since, both PTZ and picrotoxin 
induces convulsions through similar mechanism, but the reason for 
the effectiveness of the extract in one model and not in other require 
more studies.  
Ficus sycomorus L. Range 
F. sycomorus (Moraceae) is generally found in the Arabian peninsua-
la, tropical Africa to the east and Nigeria. Naturally, the tree is 
usually found in rich soils along rivers and in mixed woodlands. 
Ibrahim et al. [16] studied the anticonvulsant activity of the flavono-
ids-rich fraction of its ethanolic stem bark extract. Treatment with 
the flavonoids-rich fraction at 20 mg/kg i.p. dose significantly pro-
tected MES-induced convulsion in 30 day old white ranger cockerels 
and showed a weak anticonvulsant activity against PTZ-induced 
convulsions in mice. The flavonoids-rich fraction of the ethanolic 
stem bark extract of F. sycomorus can be further fractionated in fu-
ture to get the bioactive flavonoid(s). 
Argyreia speciosa (Burm.f.) Bojer 
Argyreia speciosa (Convolvulaceae) commonly known as Vridha 
daraka in Sanskrit and is one of the most important medicinal plant 
used in indigenous system of medicine. Its roots are regarded as an 
alternative tonic to cure nervine disorders. The major flavonoids 
isolated from the roots include, quercetin and kaempferol. Vyawa-
hare et al. [100] studied the anticonvulsant activity of the hydroal-
coholic extract of its roots in PTZ and MES mice models.  
Treatment with the extract at 200 and 400 mg/kg doses significantly 
delayed the latency to the onset and reduced the duration of convul-
sion in PTZ and MES tests, respectively. Since the plant has also 
shown nootropic effects [101], as described memory deficit is a 
major complication in epilepsy, hence activity of the plant in both 
disorders indicate its possibility in suppression of epilepsy and as-
sociated memory impairment, which can be explored in future. 
Pongamia pinnata (L.) Pierre. 
It belongs to family Febaceae and is commonly known as Karanj. 
Phytochemical studies revealed the presence of flavonoids in its 
leaves, pongol (flavone derivative), glabrachalone and isopongach-
romene in its seeds [102]. Manigauha et al. [103] reported the anti-
convulsant activity of its ethanolic leaf extract. The study showed 
that, treatment with the extract at 250 mg/kg, i.p. dose prevented 
PTZ induced convulsions in wistar albino rats. It also reported that 
flavonoids like quercetin, kaempferol present in P. pinnata are re-
sponsible for protection against PTZ induced convulsions by mod-
ulating GABAergic or glutamatergic receptor functions. 
Abutilon indicum (L.) Sweet 
Abutilon indicum (Malvaceae) commonly known as Thuthi and Ati-
bala in Ayurveda is widely used as medicine in Ayurveda for anti-
fungal, antibacterial, immunomodulator and analgesic activities 
[104]. It rich in luteolin, chrysoseriol, luteolin-7-O-β glucopyrano-
side, chrysoseriol 7-O-β glucopyranoside, apigenin 7-O-β-gluco py-
ranoside, quercetin 3-O-β-gluco pyranoside, quercetin3-O-α rham-
nopyranosyl, β-gluco pyranoside [105]. Golwala et al. [106] studied 
the ethanolic (AIE) and aqueous (AIA) leaf extracts for anticonvul-
sive properties at 100 mg/kg and 400 mg/kg p.o. against PTZ and 
MES induced convulsions. Both the extracts provided protection but 
AIE showed better significant protection than AIA against the PTZ 
and MES induced convulsions. This study also indicated flavonoids 
for its anticonvulsant effect which might be true as flavonoids are 
extracted in the alcoholic extract and this study have shown that AIE 
as better anticonvulsant than AIE.  
Hypericum perforatum L 
H. perforatum commonly known as St. John’s Wort, belongs to family 
Hypericaceae. It has been used for the treatment of epilepsy since 
antiquity. It contains high amount of flavonols (catechins) and flavo-
noids (hyperoside, quercetin, quercetrin, rutin, biapigenin, kaempfe-
rol) [107, 108]. Hosseinzadeh et al. [109] reported the anticonvul-
sant activity of its aqueous and ethanolic extracts of aerial part in 
PTZ and MES convulsion mice models. Both the extracts at 0.1-1g/kg 
i.p. dose were found to be effective in PTZ, but not in MES model. 
Further pretreatment with a nitric oxide synthase inhibitor reduced 
anticonvulsant effect of the extracts, indication the involvement of 
nitric oxide pathways for the activity of extracts. As the class of fla-
vonoids present in H. perforatum have shown anticonvulsant activity 
in other previous studies, and the role of flavonoids in the modula-
tion of nitric oxide pathway has been well established, therefore it 
can be correlated that the anticonvulsant activity of H. perforatum is 
due to flavonoids. However further studies are required to generate 
more scientific support for the safe clinical use of H. perforatum in 
epilepsy. 
Mimosa pudica L 
M. pudica (Missociaceae) commonly known as Lajvanti has been 
used for the treatment of numerous diseases related to nervous 
system. Bum et al. [110] investigated the anticonvulsant activity of 
the decoction of M. pudica leaves. Treatment with the leaf decoction 
at 1000 and 4000 mg/kg i.p. protected mice against PTZ and strych-
nine-induced convulsions. Since the leaves of M. pudica contains an 
appreciable amount of flavonoids [111], hence it is expected that the 
anticonvulsant effect of the leaves can be due to flavonoids. There-
fore further studies are required to validate the role of flavonoids for 
the anticonvulsant effect of the leaves of M. pudica.  
Butea monosperma (Lam.) Taub. 
In the Ayurveda it is known as Bastard Teak, it belongs to family 
Fabaceae. Silambujanaki et al. [112] evaluated the anticonvulsant 
activity of the methanolic leaf extract of B. monosperma in mice. 
Preliminary phytochemical screening showed the presence of fla-
vonoids. The extract at 100, 200, 400 mg/kg p.o. doses was used 
against MES, PTZ and strychnine induced seizure models. It was 
found that the extract at 400mg/kg dose was effective against MES 
and PTZ but not against strychnine induced seizures. The anticon-
vulsant activity exhibited by the extract might be due inhibitory 
effect on Na+, t-type Ca2+ channels, NMDA receptors and excitatory 
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effect on GABA aminergic mechanism. The study also suggested that 
the extract might be effective due to the presence of flavonoids in 
the extract. 
Nauclea latifolia Sm. 
It is commonly known as pin cushion tree belonging to family 
Rubiaceae. It has been experimentally studied for its anticonvulsant 
activity [113]. Aqueous extract of the bark of dried roots at 16, 40, 
80, and 160 mg/kg i.p. was studied against MES, PTZ and Strychnine 
induced seizures in mice. Study concluded that the dose of 160 
mg/kg provided significant protection against MES, PTZ and Strych-
nine induced seizures. Flavonoids present in the extract might be 
showing this activity through benzodiazepine, GABA receptors in the 
GABA receptor complex and probably by prolonging the inactivation 
of sodium channels. 
Sphaeranthus indicus L. 
It is commonly known as Gorakhmundi, which is an herb widely 
distributed in wet places of India belonging to family Compositae. 
Galani et al. [114] investigated anticonvulsant property of the hy-
droalcoholic extract of whole plant using PTZ, MES models in rats. 
Preliminary phytochemical screening revealed the presence of fla-
vonoids in the extract. Study concluded that the extract at 500 
mg/kg, p.o. dose possess CNS depressant action in addition to anti-
convulsant action. Flavonoids present in the extract might be re-
sponsible for anticonvulsant effects but needs further investigation. 
Solanum nigrum L. 
S.nigrum commonly known as Black night shade in English and 
Kakamachi in Tamil belongs to family Solanaceae. Ravi et al. [115] 
investigated the anticonvulsant activity of aqueous and ethanolic 
extract prepared from shade dried berries powder in albino rats. 
Ethanolic extract at the doses of 100, 200, 300 mg/kg, p.o. was found 
to possess anticonvulsant activity against seizures induced by MES. 
Phytochemical studies have reported the presence of flavonoids in 
aqueous and ethanolic extract. Exact mechanism of the extract 
showing anticonvulsant activity is not known but anticonvulsant 
activity might be due to stimulatory effect on GABA mediated synap-
tic inhibition which might be due to presence of flavonoids. 
Aegle marmelos (L.) Corr. 
It is commonly known as Bael belonging to family Rutaceae. Sankari 
et al. [116] investigated the anticonvulsant effects of the ethanolic 
leaf extract using MES and PTZ induced seizure model in mice. It was 
found that the administration of the extract at 200 mg/kg p.o. sig-
nificantly increased the onset, decreased the duration of MES in-
duced tonic hind limb extension. The onset of tonic convulsion pro-
duced by PTZ was also significantly delayed. As the phytochemical 
estimations revealed the presence of flavonoids, the anticonvulsant 
effect might be due to their enhancing action on GABA-mediated 
inhibition in the brain which needs further studies. 
Vitex agnus castus L. 
V. agnus commonly known as Vitagnus or Chaste tree belongs to 
family Lamiaceae. This plant has been used to treat epilepsy and 
psychosis in 1200 A.D. and is known as ‘Black remedy’. Saberi et al. 
[117] investigated the hydroethanolic extract from the fruits con-
taining flavonoid such as casticin, vitexin and orientin [118] for its 
possible anticonvulsant activity in electrical kindling model of epi-
lepsy in male albino wistar rats. The extract at 60, 120 or 180 mg/kg 
i.p. doses showed anticonvulsant property indicated by increment in 
after discharge threshold, reduction in after discharge duration and 
seizure severity in a dose dependent manner. Anticonvulsant activ-
ity might be due to flavonoids having agonist action on kappa opioid 
receptors. 
Ginkgo biloba 
G. biloba belonging to family Ginkgoaceae has various uses in tradi-
tional medicine and neurodegenerative diseases including the for-
mation of kindling epilepsy & epileptic discharge. Many flavonoids 
have been isolated from ginkgo leaves like monomer flavonoids 
(quercetin and kaempferol), dimer flavonoids (biflavone, ginkgetin, 
sciadopitysin and bilobetin). G. biloba extract can be used to prevent 
the development of epilepsy due to ischemic attacks. This is proba-
bly due to Bilobalides which appear to act at sites in the chloride 
channel of GABAA receptor and is thus a negative allosteric modula-
tors [119, 120] and due to flavonoids from G. biloba extract, for 
which it has been established that they perform modulation of ionic 
currents mediated by GABA receptors [121].  
Another experimental study reported by Ivetic et al. [122] showed 
an opposite effect of G. biloba. The experimental study reported that, 
administration of the extract had pro-epileptogenic effect, probably 
by conditioning the depolarization shift of the stimulated neurons of 
the hippocampus. They also established that some constituents of 
the extract have pro-epileptogenic effect and decrease the effect of 
antiepileptic (valproate and carbamazepine).These fully opposite 
observations, epileptogenic and anti-epileptogenic effects of G. bilo-
ba extract are mostly explained by the change of the GABA content, 
NMDA receptors, beta receptors etc. in various parts of the brain. 
These variations might be due to variation in experimental models, 
dose levels and difficulties in precise monitoring of epileptogenic 
effect, especially when the results of clinical studies are analyzed. 
Thus, whether the G. biloba has antiepileptic effect due to presence 
of flavonoids or it has pro-epileptogenic effect, it needs further in-
vestigation to establish the right connection and mechanism in-
volved in epilepsy.  
Albizia lebbeck (L.) Benth. 
It is commonly known as woman’s tongue belonging to family Faba-
ceae. Its ethanolic leaf extract has been reported to protect the mice 
from MES and PTZ induced convulsions [108] which contain flavo-
noids kaempferol and quercetin 3-O-alpha-rhamnopyranosyl(1--
>6)-beta-glucopyranosyl(1-->6)-beta- galactopyranosides. Thus the 
anticonvulsant activity might be due to presence of flavonoids which 
needs further investigation. 
Tanacetum parthenium (L.) Sch. Bip. 
T. parthenium commonly known as Feverfew belongs to family Aste-
raceae. It is a traditional medicinal herb found in many old gardens. 
The extracts of T. parthenium have been used in Danish folk medi-
cine for the treatment of epilepsy. Studies have shown that the etha-
nolic extract contain flavonoid apigenin which might be showing 
anticonvulsant effect due to its high affinity for the GABAA-
benzodiazepine site [18]. Thus flavonoids could be the active ingre-
dient in the extract for its anticonvulsant activity. 
Brahmi ghrita 
Brahmi ghrita, one of the panchgavya formulation clamed as antiepi-
leptic in ayurveda contains Bacopa moneri. Acorus calamus, Evolves 
alsinoids, Sausserea lappa out of which Bacopa moneri and Acorus 
calamus contain flavonoids which might be responsible for their 
anticonvulsant effects. 
Bacopa monniera L. Pennell  
It is commonly known as brahmi belongs to family Scrophulariaceae. 
It is used to provide relief to patients with anxiety or epileptic dis-
orders. Alcoholic leaf extract of B. monniera contains large amount of 
flavonoids [108, 123]. Kaushik et al. [124] studied the anticonvul-
sant activity of ethanolic leaf extract against PTZ, MES, strychnine, 
hypoxic stress and lithium pilocarpine induced convulsions in albino 
mice and wistar rats. It was found that the extract at 55 and 50 
mg/kg p.o. doses to mice and rats respectively was effective against 
all the models of epilepsy. Mathewa et al. [125] also reported its use 
in epilepsy associated comorbities such as learning and memory 
impairment. 
Acorus calamus L. 
Also known as Acorus odoratus and commonly known as Sweet Flag 
belongs to the family Adoraceae. It contains flavonoid Galangin (5,7-
dihdroxyflavonol) [126]. Jayaraman et al. [127] evaluated the anti-
convulsant activity of this plant using methanolic root extract at 100 
and 200 mg/kg p.o. doses against PTZ model of convulsion in swiss 
albino mice. It was found that the extract significantly increased the 
latency period and reduced the duration of seizures. The flavonoids 
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present might be responsible for the above action by exhibiting 
potentiating effect on GABAA receptors. 
Origanum vulgare 
O. vulgare commonly known as Oregano is an erectly spreading 
plant having strong aromatic characteristics in leaves belongs to 
family Lamiaceae. Its leaves contain flavonoids in addition to triter-
penoids, sterols, vitamin C, and vitamin A. In India, leaves are used 
traditionally for epilepsy, bronchitis, asthma, diarrhea, nephro-
cystolithiasi, fever, indigestion and cough [128]. Flavonoids present 
in Oregano might be responsible for their anticonvulsant action but 
further studies in this area need to be done to support this evidence. 
Moringa oleifera 
Moringa oleifera commonly known as Drumstick belongs to family 
Moringaceae. It contains flavonoids in addition to alkaloids, tannins, 
carbohydrates, amino acids, glycosides. It is reported to provide 
significant protection against strychnine and PTZ induced convul-
sions [108, 129, 130]. The exact mechanism of its anticonvulsant 
activity is not known which needs further investigation. 
Nyctanthes arbortristis  
Commonly known as Night Jasmine or Coral Jasmine belonging to 
family Oleaceae, it is an indigenous plant native of India. The etha-
nolic and aqueous leaf extract have shown to provide protected 
effect against MES and PTZ induced convulsions in mice [108, 131]. 
Phytochemical screening showed that the extract contain flavonoids 
& phenolic compounds. Flavonoids present in the extract might be 
responsible for anticonvulsant action but it needs further investiga-
tion.  
Artemesia vulgaris L. 
vulgaris commonly known as Mugwort belonging to family Astera-
ceae has a long history of medicinal use as a traditional herbal re-
medy for epilepsy. It contains twenty known flavonoids which were 
isolated and identified as tricine, jaceosidine, eupafolin, chrysoeriol, 
diosmetin, homoeriodictyol, isorhamnetin, apigenin, eriodictyol, 
luteolin, luteolin 7-glucoside, kaempferol 3-glucoside, kaempferol 7-
glucoside, kaempferol 3-rhamnoside, kaempferol 3-rutinoside, quer-
cetin 3-glucoside, quercetin 3-galactoside, quercetrin, rutin, and 
vitexin [132]. The presence of large amount of flavonoids together 
with anticonvulsant properties highlights the involvement of flavo-
noids in anticonvulsant action, which needs further investigations. 
Abrus precatorius L. 
A.precatorius commonly known as Rosary Pea belonging to family 
Fabaceae is famous for its beautiful but deadly seeds containing 
toxin abrin. The chloroform soluble fraction of the concentrated 
80% methanolic extract of the seeds contains flavonol glycosides 
which are reported to possess anticonvulsant activity [133]. Flavo-
nol glycoside has been reported to be present in this plant [134]. 
Thus flavonol glycoside might be responsible for its anticonvulsant 
action but more studies need to be done to support this evidence. 
Citrus aurantium L. 
It is commonly known as sour orange belonging to family Rutaceae. 
It is one of the medicinal plants which have been grown all over the 
world because of its high medicinal values and as a traditional drug 
in Islamic medicine. The flowers of this plant have been used to 
control seizures. Electrospray mass spectrometer (HPLC–ES-MS) 
analyzed eight flavonoids i.e. isonaringin, naringin, hesperidin, neo-
hesperidin, naringenin, hesperitin, nobiletin and tangeritin from the 
ethanolic extract of fruits showing anticonvulsant effects [135]. 
Hesperetin is able to ameliorate the response to tetraethylammo-
nium and PTZ. These flavonoids might be responsible for anticon-
vulsant action through activation of large conductance calcium de-
pendent potassium channels [136] or agonistic effect on benzodia-
zepine receptor [137]. 
Astragalus centralpinus 
It is commonly known as milk-vetch which belongs to family Papil-
ionaceae. It contain various flavonoids like 5,7,4’-trihydroxy3,3’-
dimethoxy flavone, 3,5,7,3’-tetramethoxy-4’-hydroxyflavone, 3,7-
dihydro-flavone and 4,5-dimethoxy-7- hydroxyflavan-7-ol. These 
flavonoids are reported to be effective against reversed convulsive 
action of barium chloride [9]. 
Hibiscus vitifolius L. 
H. vitifolius (Malvaceae) has been reported to contain a bioflavonoid, 
gossypin. Rasilingam et al. [138] studied the anticonvulsant activity 
of gossypin using PTZ, strychnine and MES-induced convulsion 
models in mice. Treatment with gossypin (10 and 20 mg/kg p.o.) 
significantly increased the latency to PTZ-induced convulsion. More-
over, treatment with gossypin at 20 mg/kg dose showed significant 
protection against strychnine and MES-induced convulsions. How-
ever more studies are required to understand the exact anticonvul-
sant mechanism of gossypin. 
 
Table 1: It shows the comprehensive list of some herbal plants with anticonvulsant activity. 
Plant  Family Reported flavon-
oid(s) 









Fabaceae Flavonol glycosides are 
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-xyloside has been 
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be responsible for its anti-
convulsant action but more 
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Malvaceae Luteolin, chrysoseriol, 
luteolin-7-O-β gluco 
pyranoside, chrysose-







yl, β-gluco pyranoside. 
 
Leaves Ethanolic and 
aqueous ex-
tracts.  
100 mg/kg and 
400 mg/kg p.o./ 
PTZ and MES 
model/ wistar 
rats. 
Ethanolic extract showed 
better protection than 
aqueous extract. Ethanolic 
extract gave significant 
protection against the PTZ 




Acorus Adoraceae Galangin (5,7- Roots Methanolicex- 100 and 200 Extract significantly in- [126, 
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calamus L. dihdroxyflavonol). tract mg/kg p.o./ 
PTZ/ swiss 
albino mice. 
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of seizures. The flavonoids 
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extract.  
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The action might be due 
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through activation of GABA 
[89] 
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It was found that the activ-
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Rutaceae Isonaringin, naringin, 
hesperidin, neohespe-
ridin, naringenin, hes-
peritin, nobiletin and 
tangeritin. 




and PTZ model. 
Flavonoids might be re-
sponsible for anticonvul-
sant action through activa-
tion of large conductance 
calcium dependent potas-
sium channels or agonistic 











Seeds  Alcoholic and 
aqueous ex-
tract. 
200, 400 and 
600mg/kg p.o./ 
MES and PTZ 
models/ swiss 
albino mice. 
The anticonvulsive effect 
might be because of fla-
vonoids attributed due to 
inhibitory effect on voltage 
dependent sodium chan-





















may be attributed due to 
flavonoids causing reduc-
tion of T-type calcium cur-
rents, enhancement of 
GABAA-BZD receptor activi-
ty and blocking of glutame-
targic excitation mediated 
















400mg/kg dose completely 
abolished the seizures 
induced by picrotoxin and 









Stem, bark Crude flavono-




5, 10 and 20 
mg/kg i.p./ PTZ 
and MES mod-
els/ mice and 
chicks respec-
tively 
Crude flavonoid rich ex-
tract revealed a significant 
activity in MES test and a 
weak anticonvulsant activi-
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G. glabra might be active 
against petitmal or absence 













It shows anticonvulsant 
activity probably by en-
hancing GABA transmis-
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Extract is effective against 









Leaves  Decoction  1000–4000 
mg/kg i.p./ PTZ 
and strychnine-
model/ mice 
The decoction showed 
protected effect in mice 











TNA TNA TNA It is reported to provide 
significant protection 












dried roots  
Aqueous ex-
tract of the 
bark of dried 
roots  
16, 40, 80, and 
160 mg/kg i.p./ 
MES, PTZ and 
strychnine 
models/ mice. 
Flavonoids present in the 
extract might be showing 
activity against MES, PTZ 
and Strychnine induced 
seizures through benzodi-
azepine, GABA or by pro-








TNA Ethanolic and 
aqueous ex-
tract of leaves. 
TNA Flavonoids present in the 
extract might be responsi-








Lamiaceae Cirsimaritin (flavone) Leaves Methanolic 
and petroleum 
ether extracts. 
200 and 400 
mg/kg p.o./ PTZ 
model/ mice. 
Extracts increased the 
latency of seizures and 














0.05, 0.1, 0.2, 
0.4 mg/kg i.p. / 
PTZ model/ 
mice. 
The active constituent can 
be flavonoid chrysin which 
might be acting as a partial 
agonist at benzodiazepine 
receptor with micromolar 
affinity or through opioid 
receptors. But it still re-
mains controversial 
whether chrysin is actually 
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30, 60, 90, and 
150 mg/kg i.p. / 
Pilocarpine and 
PTZ model/ rats 
Anticonvulsant effect might 
be due to high affinity for 
the benzodiazepine binding 







Berries  Aqueous and 
ethanolic ex-
tract  




Ethanolic extract was 
found to be effective at all 
the doses. Anticonvulsant 
activity present might be 
due to stimulatory effect on 
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100, 200 and 
500 mg/kg p.o./ 
PTZ and MES 
model/ rats. 
500 mg/kg p.o. possesses 
CNS depressant action in 













search on this 
topic need to be 
done. 
Anticonvulsant effect might 
be due to high affinity of 
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Lamiaceae Flavonoids such as 
casticin, vitexin and 
orientin are present. 
Fruits  Hydroalcoholic 
extrct  
60, 120 or 180 




Extract showed increment 
in after discharge thresh-
old, reduction in after dis-
charge duration and stage 














and PTZ models 
V. negundu leaf extracts are 
not just anticonvulsant but 
also have synergistic activ-




TNA- Text Not Available 
 
CONCLUSION 
Flavonoids emerged as a very valuable class of secondary metabolite 
having potential for the comprehensive treatment of epilepsy. As 
future investigations continue, this class may prove to be a rich 
source of new molecules for the development of new therapeutic 
agents for the treatment of epilepsy. During our literature review we 
observed the modulatory role of flavonoids in almost all the neuron-
al pathways involved in the pathogenesis of epilepsy. Studies carried 
out till date suggests that flavonoids inhibit voltage gated sodium 
channels, activate Ca+activated K+ channels, stimulate GABAergic 
inhibition, interact with opioid receptors, inhibit NMDA receptors 
and exhibit antioxidant actions via modulation of nitric oxide and 
xanthine oxidase pathways and by leukocytic immobilization, one or 
more of these mechanisms are involved in suppression of epileptic 
seizures. Hispidulin, rutin, hesperetin, naringenin, eriodictyol, chry-
sin, gossypin, apigenin, kaempferol, myricetin, quercetin, hoslundin, 
hoslundal, hoslunddiol, morine, amentoflavone, hyperoside, anghy-
peroside, epicatechin, rutin, silibin and luteolin are some of the im-
portant flavonoids that possess one or more of the above mentioned 
mechanisms.  
Copious studies pertaining to the anticonvulsant potential crude 
extracts containing flavonoids and flavonoids-rich fraction contain-
ing uncharacterized flavonoids have been carried out. Thus, it is 
difficult to reproduce the results of these studies and pinpoint the 
bioactive flavonoids. Hence, there is a need of phytochemical stan-
dardization and bioactivity-guided identification of bioactive flavo-
noids. Moreover it is expected that bioactivity-guided fractionation 
of the extracts and the rich fractions will yield new flavonoidal mo-
lecules. In several instances even where the active anticonvulsant 
flavonoids is known, their mechanism of action is missing, which 
needs further studies. 
Since oxidative injury play a vital role in the initiation and progres-
sion of epilepsy, current treatment strategies are aimed on reducing 
oxidative stress to ameliorate tissue damage and to alter the clinical 
course of the disease [13, 139]. It has been reported that free radical 
generation induces seizure activity by inactivation of glutamine 
synthase, thereby permitting an abnormal build-up of excitatory 
neurotransmitter, glutamate [140] or by inhibition of glutamate 
decarboxylase, leading to decrease in GABA turnover in turn facili-
tating abnormal excitation [141]. Oxidative stress also plays an im-
portant role in the etiology of seizure induced neuronal death [142]. 
Since flavonoids shows a strong antioxidant effects as they have a 
highly reactive hydroxyl group in their structure, therefore provide a 
direct radical scavenging activity [39], hence ameliorate epileptic 
condition [13]. In several studies the antioxidant effect of the active 
flavonoids, flavonoids-rich fraction and flavonoids containing crude 
extracts was studied in in vitro studies, therefore further in vivo 
studies are required to further explore their clinical effectiveness 
and therapeutic potential.  
Treatment of epilepsy includes the use of multiple dose regimens for 
prolonged periods, making the side and adverse effects inevitable to 
the patients. It has been suggested that these ill effects can be de-
creased by reducing the dose of antiepileptics and/or prescribing 
substances that can potentiate the effect of former and decrease 
unwanted effects [143]. Some studies depicted the synergistic anti-
epileptic effect of flavonoids with clinically used antiepileptic drugs. 
For example, apigenin and (-) epigallocatechin potentiates the the-
rapeutic effect of diazepam [26]. As flavonoids are devoid of side 
effects which are commonly associated with clinically used antiepi-
leptic drugs like, ataxia, amnesia, etc, therefore in future these flavo-
noids can be supplemented antiepileptic drugs to reduce the dose of 
later to limit side effects.  Flavonoids not only suppress epilepsy but 
also found to be effective against epilepsy-induced comorbidities. 
Activation of ERK and CREB pathway helps in treating amnesia, 
while its antioxidant property helps to mitigate depression (Fig. 4). 
Flavonoids extracted from plants are known to exert antidepressant 
like effects in animal models of depression [68, 69].  
Flavonoids, mainly flavonols like quercetin and kaempferol are re-
sponsible for reversing oxidative stress induced-decrease of hippo-
campal BDNF and pCREB expression leading to hippocampal neuro-
genesis and thus, ameliorating depression [37, 38]. Similar im-
provement is also reported in the learning and memory with the use 
of flavonoids possibly via prohibiting oxidative stress [144-146].  
With few exceptions, in majority of studies flavonoids have been 
found to cross blood brain barrier, indicated by there observed neu-
rological effects. Youdim et al. [147] studied citrus flavonoids, hes-
peretin, naringenin and their relevant in vivo metabolites, as well as 
the dietary anthocyanins and in vivo forms, cyanidin-3-rutinoside 
and pelargonidin-3-glucoside in vitro models (brain endothelial cell 
lines from mouse (b.END5), rat (RBE4) and ECV304 monolayersco-
cultured with C6 glioma cells). The study reported that flavonoids 
and its metabolites are able to travel through the blood brain barrier 
which is consistent with compound lipophilicity.  
However, there are reports of toxic flavonoid-drug interactions, liver 
failure, contact dermatitis, hemolytic anemia, and estrogenic-related 
concerns such as male reproductive health and breast cancer asso-
ciated with dietary flavonoid consumption [148]. Controlled clinical 
trials of flavonoids and their potential for toxicity is an understudied 
aspect till now, therefore it needs due attention and research before it 
gets too late. It is expected that systematic, preclinical and clinical studies 
will be undertaken in future in the above mentioned areas, so that the 
great potential of flavonoids to assist people living with epilepsy and 
other related ailments can be explored. 
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Fig. 4: Role of flavonoids in treating epilepsy-induced depression and cognition deficit via ameliorating oxidative stress. 
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